Translocations and intracellular immunotherapy
Our group is working on cancer-associated chromosomal translocation protein products and using antibody fragments to interfere with function in vivo. The aim is to develop an intracellular immunotherapy platform for cancer treatment.
Keywords
Molecular biology of leukemia / chromosomal translocations / haematopoiesis / experimental therapeutics / cancer biology / LMO2